ChemPartner PharmaTech Co Ltd Cash Flow Conversion Efficiency
ChemPartner PharmaTech Co Ltd cash flow conversion efficiency. Based on the latest financial reports, ChemPartner PharmaTech Co Ltd (300149) has a cash flow conversion efficiency ratio of 0.012x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥28.21 Million ≈ $4.13 Million USD) by net assets (CN¥2.37 Billion ≈ $347.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of ChemPartner PharmaTech Co Ltd (2007–2025)
Cash flow conversion efficiency of ChemPartner PharmaTech Co Ltd from 2007 to 2025. This chart illustrates how ChemPartner PharmaTech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300149 stock price and chart for real-time trading data and today's change.
ChemPartner PharmaTech Co Ltd Cash Flow Conversion Ratio Explained
ChemPartner PharmaTech Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
ChemPartner PharmaTech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ChemPartner PharmaTech Co Ltd ranked by their cash flow conversion efficiency. Also see ChemPartner PharmaTech Co Ltd market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zero One Technology Co Ltd
TW:3029
|
-0.020x |
|
Jianglong Shipbuilding Co Ltd
SHE:300589
|
0.284x |
|
Henan Ancai Hi-tech Co Ltd
SHG:600207
|
-0.033x |
|
Sharda Cropchem Limited
NSE:SHARDACROP
|
0.226x |
|
Jiangyin Haida Rubber and Plastic Co Ltd Class A
SHE:300320
|
0.016x |
|
Huarui Electrical Appliance Co Ltd
SHE:300626
|
-0.015x |
|
Drugs Made In America Acquisition II Corp. Ordinary Shares
NASDAQ:DMII
|
0.000x |
|
Pet Acquisition LLC
NASDAQ:WOOF
|
-0.051x |
Annual Cash Flow Conversion Efficiency for ChemPartner PharmaTech Co Ltd (2007–2025)
The table below shows the annual cash flow conversion efficiency of ChemPartner PharmaTech Co Ltd from 2007 to 2025. Review 300149 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.30 Billion ≈ $190.28 Million |
CN¥190.50 Million ≈ $27.88 Million |
0.146x | +7.83% |
| 2024-12-31 | CN¥1.24 Billion ≈ $181.17 Million |
CN¥168.21 Million ≈ $24.61 Million |
0.136x | +31.45% |
| 2023-12-31 | CN¥1.46 Billion ≈ $213.77 Million |
CN¥150.99 Million ≈ $22.09 Million |
0.103x | -6.04% |
| 2022-12-31 | CN¥2.39 Billion ≈ $349.14 Million |
CN¥262.46 Million ≈ $38.41 Million |
0.110x | -42.15% |
| 2021-12-31 | CN¥1.99 Billion ≈ $291.06 Million |
CN¥378.22 Million ≈ $55.35 Million |
0.190x | +35.89% |
| 2020-12-31 | CN¥2.45 Billion ≈ $358.86 Million |
CN¥343.16 Million ≈ $50.22 Million |
0.140x | +49.86% |
| 2019-12-31 | CN¥2.30 Billion ≈ $337.05 Million |
CN¥215.07 Million ≈ $31.47 Million |
0.093x | -15.36% |
| 2018-12-31 | CN¥2.20 Billion ≈ $322.59 Million |
CN¥243.19 Million ≈ $35.59 Million |
0.110x | +45.29% |
| 2017-12-31 | CN¥835.45 Million ≈ $122.25 Million |
CN¥63.43 Million ≈ $9.28 Million |
0.076x | -17.96% |
| 2016-12-31 | CN¥769.93 Million ≈ $112.67 Million |
CN¥71.26 Million ≈ $10.43 Million |
0.093x | -33.47% |
| 2015-12-31 | CN¥723.81 Million ≈ $105.92 Million |
CN¥100.69 Million ≈ $14.73 Million |
0.139x | +62.47% |
| 2014-12-31 | CN¥696.53 Million ≈ $101.92 Million |
CN¥59.63 Million ≈ $8.73 Million |
0.086x | +23.89% |
| 2013-12-31 | CN¥670.29 Million ≈ $98.08 Million |
CN¥46.32 Million ≈ $6.78 Million |
0.069x | -19.60% |
| 2012-12-31 | CN¥640.90 Million ≈ $93.78 Million |
CN¥55.09 Million ≈ $8.06 Million |
0.086x | +350.62% |
| 2011-12-31 | CN¥611.46 Million ≈ $89.48 Million |
CN¥11.66 Million ≈ $1.71 Million |
0.019x | -47.63% |
| 2010-12-31 | CN¥571.30 Million ≈ $83.60 Million |
CN¥20.81 Million ≈ $3.05 Million |
0.036x | -72.23% |
| 2009-12-31 | CN¥101.26 Million ≈ $14.82 Million |
CN¥13.28 Million ≈ $1.94 Million |
0.131x | -64.72% |
| 2008-12-31 | CN¥58.36 Million ≈ $8.54 Million |
CN¥21.70 Million ≈ $3.18 Million |
0.372x | -59.35% |
| 2007-12-31 | CN¥24.25 Million ≈ $3.55 Million |
CN¥22.19 Million ≈ $3.25 Million |
0.915x | -- |
About ChemPartner PharmaTech Co Ltd
ChemPartner PharmaTech Co.,Ltd. engages in the microecological nutrition and healthcare businesses worldwide. The company operates in two segments, Microecological Nutrition and Medical Business; and Pharmaceutical Research and Development Service and Production Outsourcing Business. It offers prebiotic products and the provision of microecological medical services. The company provides comprehen… Read more